The role of oncogenes in pituitary tumorigenesis remains elusive since few genetic changes have been identi®ed so far in pituitary tumors. Pituitary tumortransforming gene (pttg) has been recently cloned from rat GH4 pituitary tumor cells. We have previously isolated and characterized hpttg from human thymus. In the present study, we analyse the expression of hpttg mRNA in a series of human pituitary adenomas. We show that hpttg is highly expressed in the majority of pituitary adenomas while only very low levels of mRNA can be detected in normal pituitary gland by Northern blot analysis. hPTTG protein was immunolocalized mainly in the cytoplasm of adenoma cells. Other common extra-cranial malignant tumors were also analysed by immunohistochemistry. Interestingly, strong hPTTG immunoreactivity was detected in most adenocarcinomas of mammary and pulmonary origins.
Introduction
Pituitary tumors are mostly histologically benign neoplasms which account for 10 ± 15% of all primary intracranial tumors. Since pituitary tumors arise from the dierent hormone-secreting cell types of the adenohypophysis, they are classi®ed mainly on the basis of their endocrine secretory activity (Thapar et al., 1995) . The fact that the majority of pituitary adenomas are monoclonal in origin (Alexander et al., 1990; Herman et al., 1990) strongly suggests that the occurrence of molecular events in a progenitor cell leads to tumor formation. However, the genetic defects so far identi®ed in pituitary tumors are scanty. G s asubunit gene point mutations result in the constitutive activation of adenyly cyclase and have been identi®ed in about 30% of GH-secreting pituitary adenomas in dierent series of patients (Landis et al., 1989; Lyons et al., 1990) . Activating mutations of ras and protein kinase C genes have been reported in rare aggressive tumors (Pei et al., 1994; Alvaro et al., 1993; Karga et al., 1992) . Alterations of tumor suppressor genes such as RB or p53 are very infrequent (Cryns et al., 1993; Herman et al., 1993; Sumi et al., 1993) , and the rate of men1 gene deletion or mutation seems to be low in sporadic pituitary tumors (Zhuang et al., 1997) . Recently, a pituitary tumor-transforming gene (pttg) has been isolated from clonal rat GH4 pituitary tumor cells, and is dierentially expressed in these cells but not in normal rat pituitary gland. Transformation in vitro of 3T3 ®broblasts induced by pttg overexpression and tumor formation in athymic nude mice after injection of transfected cells suggest a role for this gene in pituitary tumorigenesis (Pei and Melmed, 1997) . In our laboratory, a human cDNA homologue of pttg, hpttg, has been previously cloned from a human thymus cDNA library (DomõÂ nguez et al., 1998) . To investigate the role of hpttg in human pituitary tumorigenesis, we examined its expression in normal human pituitary gland and dierent types of hormonesecreting and nonfunctioning human pituitary adenomas. As preliminary data suggested that hpttg is expressed in dierent cell lines derived from malignant tumors, we also investigated the expression of this gene in common primary epithelial malignancies.
Results
To investigate the expression of hpttg in normal human pituitary gland and in human pituitary adenomas, total RNA was analysed by Northern blots using the complete hpttg cDNA sequence as a probe. A single band of approximately 900 bp was mainly detected in pituitary adenoma tissues. As shown in Figure 1a , high level of expression was observed in all pituitary adenomas analysed, while expression in samples corresponding to normal pituitary glands either from surgical or cadaveric material remained undetectable or very low even after long ®lm exposure. The relative levels of hpttg mRNA, after adjusting for uneven amounts of RNA loaded on the gel, are illustrated in Figure 1b . The mean value for the hybridization intensity in the normal gland was only 13% of that found in the adenomas. The gene expression level in the analysed tumors greatly exceeded that of the benign tissues, showing the highest expression the H241 and H845 GS adenomas samples.
The eciency of antibody anti-hPTTG on paran sections allowed us to screen a series of 36 hormonesecreting and nonfunctioning pituitary adenomas from routine formalin-®xed, paran-embedded surgical material by immunohistochemistry. A positive cytoplasmic immunostaining (Figure 2 ) was obtained in all but four adenomas (two nonfunctioning, one PRL, one ACTH). Nuclear staining was detected in few cells. Immunostaining was absent in most sections corresponding to normal pituitaries from surgical or cadaveric material, although occasional single cells appeared faintly stained. A series of adenocarcinomas from common extra-cranial sites was also tested by immunohistochemistry using routine surgical paranembedded material. Most breast and lung adenocarcinomas in this series (14/18 cases and 9/10, respectively) showed a positive PTTG immunostaining. Immunoreactivity was again mostly cytoplasmic, but stained nuclei were more frequently detected (Figure 3a and b). Positive cases were observed among other adenocarcinomas but the series were not large enough to be signi®cantly estimated.
Discussion
The molecular basis of pituitary tumorigenesis has been the subject of intensive research in the last two decades. Recent contributions have provided evidence supporting two general theories; that either abnormal regulation by hypothalamic and autocrine growth factors or intrinsic genetic alterations might lead to tumor initiation and promotion in the adenohypophysis (Spada et al., 1994) . To date, few genetic abnormalities have been identi®ed in pituitary tumors. Activating mutations of G s alpha, termed gsp, are the best characterized oncogenes in pituitary adenomas (Landis et al., 1989; Lyons et al., 1990) . Constitutively activated gsp could stimulate cell proliferation through the induced expression of CREB-dependent transcription factors pit-1 and c-fos (Bertherat et al., 1995) . However, at least two-thirds of GH-secreting adenomas and most of the other types of pituitary adenomas do not harbor gsp mutations. It is likely that pituitary cell transformation requires more than a single genetic mutational event. In fact, targeted expression of cholera toxin, which activates adenylyl cyclase in a similar manner to gsp mutations, induces somatotroph hyperplasia but not adenomas in the pituitary gland of transgenic mice (Burton et al., 1991) . By using mRNA PCR dierential display, Pei and Melmed (1997) isolated pttg from rat pituitary tumor GH4 cells. These authors showed that rat pttg overexpression resulted in cell transformation in vitro and induced in vivo tumor formation in athymic mice.
We have recently cloned a human homolog of pttg from a Jurkat cell cDNA library by a yeast two-hybrid screen for proteins interacting with Grb-3.3 (Dom-õÂ nguez et al., 1998). In the present study, we have shown that hpttg is overexpressed in pituitary adenomas while in non-neoplastic pituitary cells hpttg expression was either undetectable or detected at very low levels. The fact that the pituitary adenomas analysed in this study overexpress this protein independently of the cell-speci®c type supports the hypothesis that abnormal regulation of hpttg transcription could be a critical event in pituitary tumorigenesis. Transgenic models of trophic growth factor overexpression show in some cases (i.e., GHRH, TGFalpha) pituitary cell-speci®c adenomas (Asa et al., 1992; McAndrew et al., 1995) . The pttg gene could share in common pathways.
The mechanisms leading to overexpression of pttg and its action on normal and neoplastic cells remain, to our knowledge, largely unidenti®ed. hpttg has been mapped to chromosome 5q33 (Zhang et al., 1999) . This region is associated with reports of neoplastic diseases, including myeloid leukemia, chronic myeloproliferative disorders, myelodysplastic syndromes, squamous cell carcinoma, and lipoma (Strausberg et al., 1997) . hpttg cDNA isolated from a Jurkat cell cDNA library shares identical coding region sequence with six new thymus hpttg cDNA clones, as well as with a partial sequence of human placenta hpttg genomic clone (DomõÂ nguez et al., 1998 and unpublished results). Nevertheless, the search for mutations outside the coding region remains to be addressed. In a recent report, it has been documented that human hpttg is able to transform NIH3T3 cells in vitro and induce tumor formation in vivo when stably transfected NIH3T3 cells were injected into athymic mice (Zhang et al., 1999) . These results, that mirror those for rat pttg, support the hypothesis that hpttg gene overexpression could be causative in some tumors. However, correlation between hpttg expression and cell proliferation has been observed in non-transformed cells (F RamosMorales, personal communication), which, in turn, would suggest that hpttg gene expression could be also a consequence of the cell proliferation deregulation.
Although there are no well characterized functional motifs in the amino acid sequence of PTTG protein, we have previously shown that the protein contains an amino-terminal basic domain and a carboxyl-terminus acidic domain. The C-terminal region have PXXP motifs involved in the interaction with the SH3 domains of the adapter protein Grb3.3 (DomõÂ nguez et al., 1998). More recently it has been shown that when these prolines residues are changed by sitedirected mutagenesis, hPTTG in vitro transforming and in vivo tumor-inducing activity is abrogated (Zhang et al., 1999) . These results indicate that hPTTG may be involved in SH3-mediated signal transduction pathways. Furthermore, we have shown that hPTTG carboxyl terminus is able to activate transcription in the yeast and mammalian cells (DomõÂ nguez et al., 1998) . In the present study, we have localized PTTG primarily in the cytoplasm, though immunostaining was also observed in scattered nuclei. This is in agreement with previous results obtained by subcellular fractionation (DomõÂ nguez et al., 1998) . Known transcription factors involved in mitogenesis in hormone-responsive cells such as STAT proteins migrate into the nucleus when they become phosphorylated (Liu et al., 1997) . PTTG contains numerous potential phosphorylation sites for casein kinase II, PKA and PKC although their functionality has not yet been determined.
Our data suggest that hpttg is also expressed in other nonpituitary tumors. Breast and lung adenocarcinomas consistently express PTTG on immunohistochemical analyses. Pathogenesis of malignant tumors is most frequently a multistep process, in which PTTG could be involved in speci®c cancer types. Interestingly, nuclear localization of PTTG seems to be more frequent in these malignant tumors, an observation that could indirectly implicate this protein in pathways leading to cell proliferation.
In summary, we have documented that hpttg is highly expressed in human pituitary adenomas where it might play a key role in tumorigenesis. It remains to be determined if overexpression of hpttg is a primary or, more likely, secondary event in the pathogenesis of pituitary adenomas and whether its overexpression is necessary and/or sucient to promote pituitary tumorigenesis. We have also shown that expression of hpttg is not restricted to pituitary tumors since our preliminary data demonstrate the expression of hpttg in other malignant epithelial tumors. Further studies are needed to address the frequency and clinical relevance of hpttg overexpression in human tumors.
Materials and methods

Tissue samples
Pituitary tumors were collected immediately after transsphenoidal surgery for examination and processing. Some fragments were formalin-®xed and paran-embedded for histology and immunohistochemistry. Other fragments were snap frozen and stored at 7808C for molecular and immunochemical analyses. Diagnosis of individual tumors is established postoperatively on the basis of clinical and imaging features, histology, pituitary hormone immunohishpttg expression in pituitary adenomas C Sa Â ez et al tochemistry and ultrastructure. Thirty-six pituitary adenomas were included in this study (11 nonfunctioning, six GH, four PRL, ®ve GH+PRL, nine ACTH, one FSH+LH). Two surgical specimens from transsphenoidal resection in patients with Cushing's disease containing no tumor or hyperplastic foci were considered to be`normal' adenohypophysis. Seven additional normal anterior pituitary controls were obtained from medical autopsies. For immunohistochemical analysis, paran-embedded tissue blocks corresponding to adenocarcinomas of dierent common sites (lung, breast, stomach, large intestine, and prostate) were randomly selected from archival material.
RNA preparation and Northern blot analysis
Total RNA was prepared using TRIZOL Reagent (GIBCO ± BRL). In brief, 50 ± 100 mg of each tissue samples were homogenized in 1 mL of TRIZOL Reagent. After incubating at room temperature for 5 min, 1/5 vol of chloroform was added followed by vigorous shaking and incubation of 2 ± 3 min. The aqueous phase was removed after centrifugation and precipitated with 100% isopropanol. The RNA was pelleted by centrifugation and washed once with 75% ethanol. After air-drying, the RNA was dissolved in RNase-free water. Concentration was determined by spectrophotometry. Samples of 10 mg of total RNA were resolved by electrophoresis on 1% agarose-formaldehyde gels and transferred onto nylon membranes. These were then hybridized to the full-length hpttg cDNA probe (Dom-õÂ nguez et al., 1998) and washed under stringent conditions. The level of hpttg mRNA was adjusted relative to the amount of 18S rRNA after scanning of the autoradiograms in a BioRad Densitometer and using the Molecular Analyst software.
Immunohistochemistry
A polyclonal antibody was generated in rabbit using a GST fusion protein containing the amino terminal (amino acids 1 ± 123) hPTTG sequence (DomõÂ nguez et al., 1998) . The speci®city of this anti-hPTTG antibody was enlightened by competition experiments either with histidine tagged hPTTG or GST protein. Twenty mg of bacterially expressed 6His-hPTTG or GST were electrophoresed and blotted to a nitrocellulose ®lter. This ®lter was incubated with the antihPTTG antibody for 4 h before a Western blot experiment. The serum preincubated with 6His-hPTTG was no longer able to recognize hPTTG protein whereas GST had no eect. For immunohistochemistry, 5 mm sections from paran tissue blocks were deparanized and rehydrated. After blocking non-speci®c binding sites with normal swine serum, the sections were incubated overnight with primary anti-hPTTG antibody (1 : 200 dilution) at 48C. Biotinylated secondary antibody and avidin-biotin-peroxidase complex were applied according to manufacturer's instructions (LSAB2 Kit, Dako). Diaminobenzidine was used as the chromogenic substrate for visualization. Sections where primary antibody was omitted were used as negative controls in every experimental procedure. For speci®city control, tissue sections were incubated with antiserum previously absorbed with 0.1 ± 1 nmol/mL of 6His-hPTTg protein. This treatment abrogated the immunoreactivity.
